Guggenheim Downgrades Principia Biopharma (PRNB) to Neutral, Following Acquisition
Tweet Send to a Friend
Guggenheim analyst Yatin Suneja downgraded Principia Biopharma (NASDAQ: PRNB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
